$317 Million is the total value of BOONE CAPITAL MANAGEMENT LLC's 13 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 46.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNM | Buy | UNUM GROUP | $42,675,522 | +4.3% | 867,565 | +1.2% | 13.46% | -8.3% |
| CI | Buy | THE CIGNA GROUP | $37,165,356 | +19.8% | 129,917 | +17.5% | 11.72% | +5.3% |
| MOH | Buy | MOLINA HEALTHCARE INC | $37,109,934 | +15.7% | 113,178 | +6.3% | 11.71% | +1.6% |
| DHR | Buy | DANAHER CORPORATION | $32,045,340 | +21.5% | 129,163 | +17.5% | 10.11% | +6.8% |
| Buy | ENOVIS CORPORATION | $26,509,006 | -3.4% | 502,731 | +17.5% | 8.36% | -15.1% | |
| AMGN | Buy | AMGEN INC | $26,372,344 | +42.3% | 98,126 | +17.5% | 8.32% | +25.0% |
| BIIB | Buy | BIOGEN INC | $24,702,516 | +37.9% | 96,115 | +52.9% | 7.79% | +21.2% |
| GMED | New | GLOBUS MED INCcl a | $21,272,642 | – | 428,452 | +100.0% | 6.71% | – |
| BAX | Sell | BAXTER INTL INC | $17,715,345 | -43.5% | 469,405 | -31.7% | 5.59% | -50.3% |
| QTRX | Buy | QUANTERIX CORP | $15,430,284 | +36.5% | 568,544 | +13.4% | 4.87% | +20.0% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $15,397,000 | +32.0% | 570,682 | +15.0% | 4.86% | +16.0% |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $12,317,396 | – | 389,791 | +100.0% | 3.89% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $8,263,857 | – | 313,381 | +100.0% | 2.61% | – |
| CPSI | Exit | COMPUTER PROGRAMS & SYS INC | $0 | – | -349,245 | -100.0% | -3.10% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -300,000 | -100.0% | -3.42% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -88,026 | -100.0% | -4.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNUM GROUP | 4 | Q3 2023 | 15.9% |
| THE CIGNA GROUP | 4 | Q3 2023 | 12.3% |
| MOLINA HEALTHCARE INC | 4 | Q3 2023 | 11.7% |
| DANAHER CORPORATION | 4 | Q3 2023 | 10.4% |
| ENOVIS CORPORATION | 4 | Q3 2023 | 9.8% |
| BIOGEN INC | 4 | Q3 2023 | 7.8% |
| QUANTERIX CORP | 4 | Q3 2023 | 4.9% |
| AMGEN INC | 3 | Q3 2023 | 9.0% |
| BAXTER INTL INC | 3 | Q3 2023 | 11.2% |
| ABBVIE INC | 3 | Q2 2023 | 6.6% |
View BOONE CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View BOONE CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.